RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Drug-Eluting Stents Prevent Death, MI, and Revascularization in Patients with Diabetes
JF MD Conference Express
YR 2009
FD SAGE Publications
VO 8
IS 8
SP 15
OP 16
DO 10.1177/155989770900800807
UL http://mdc.sagepub.com/content/8/8/15.abstract
AB For patients with diabetes who undergo percutaneous coronary intervention (PCI), drug-eluting stents (DES) reduce the risk of mortality, acute myocardial infarction (MI), and repeat revascularization compared with bare-metal stents (BMS). These 3-year findings from the Massachusetts Data Analysis Center Registry (Mass-DAC), which requires mandatory reporting and follow-up, reflect achievable treatment outcomes in the real-world clinical setting, researchers reported.